I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Boeree, Aurélie
30
results:
Format
Online (30)
Mediatypes
Articles (Online) (11)
OpenAccess-fulltext (19)
Sorted by: Relevance
Sorted by: Year
?
1
Oncogenic and immunological targets for matched therapy of ..:
Boer, Judith M.
;
Ilan, Uri
;
Boeree, Aurélie
...
HemaSphere. 8 (2024) 7 - p. , 2024
Link:
https://doi.org/10.1002/..
?
2
Targeted treatment options for paediatric B-cell precursor ..:
Michels, Naomi
;
Hormann, Femke M.
;
Boeree, Aurélie
...
EJC Paediatric Oncology. 3 (2024) - p. 100140 , 2024
Link:
https://doi.org/10.1016/..
?
3
Tyrosine kinase inhibitor response of ABL-class acute lymph..:
van Outersterp, Inge
;
Tasian, Sarah K.
;
Reichert, Caitlin E. J.
...
Blood. 143 (2024) 21 - p. 2178-2189 , 2024
Link:
https://doi.org/10.1182/..
?
4
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1–p..:
van Outersterp, Inge
;
Boer, Judith M.
;
van de Ven, Cesca
...
Blood Advances. 8 (2024) 8 - p. 1835-1845 , 2024
Link:
https://doi.org/10.1182/..
?
5
Integrating copy number data of 64 iAMP21 BCP-ALL patients ..:
Hormann, Femke M.
;
Hoogkamer, Alex Q.
;
Boeree, Aurélie
...
Frontiers in Oncology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
6
Characterization of a novel MEF2D-BCL9 fusion positive acut..:
Van Outersterp, Inge
;
Hormann, Femke M.
;
Hoogkamer, Alex Q.
...
Haematologica. , 2023
Link:
https://doi.org/10.3324/..
?
7
P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD C..:
Boer, Judith M.
;
Ilan, Uri
;
Hoen, Babette D.J.
...
HemaSphere. 7 (2023) S3 - p. e0856830 , 2023
Link:
https://doi.org/10.1097/..
?
8
Ibrutinib is not an effective drug in primografts of TCF3-P..:
van de Ven, Cesca
;
Boeree, Aurélie
;
Stalpers, Femke
..
Translational Oncology. 13 (2020) 10 - p. 100817 , 2020
Link:
https://doi.org/10.1016/..
?
9
Copy number alterations in B-cell development genes, drug r..:
Steeghs, Elisabeth M. P.
;
Boer, Judith M.
;
Hoogkamer, Alex Q.
...
Scientific Reports. 9 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1038/..
?
10
JAK2 aberrations in childhood B-cell precursor acute lympho..:
Steeghs, Elisabeth M.P.
;
Jerchel, Isabel S.
;
de Goffau-Nobel, Willemieke
...
Oncotarget. 8 (2017) 52 - p. 89923-89938 , 2017
Link:
https://doi.org/10.18632..
?
11
Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acu..:
Boer, Judith M.
;
Steeghs, Elisabeth M.P.
;
Marchante, João R.M.
...
Oncotarget. 8 (2016) 3 - p. 4618-4628 , 2016
Link:
https://doi.org/10.18632..
?
12
P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD C..:
Boer, Judith M
;
Ilan, Uri
;
Hoen, Babette D.J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428480/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
13
Characterization of a novel MEF2D-BCL9 fusion-positive acut..:
van Outersterp, Inge
;
Hormann, Femke M
;
Hoogkamer, Alex Q
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542830/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
14
Integrating copy number data of 64 iAMP21 BCP-ALL patients ..:
Hormann, Femke M
;
Hoogkamer, Alex Q
;
Boeree, Aurélie
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996016/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
15
Ibrutinib is not an effective drug in primografts of TCF3-P..:
van de Ven, Cesca
;
Boeree, Aurélie
;
Stalpers, Femke
..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306596/. , 2020
Link:
http://www.ncbi.nlm.nih...
1-15
